Fertility and Sterility
Volume 94, Issue 5 , Pages 1757-1763 , October 2010

The effect of duration of coasting and estradiol drop on the outcome of assisted reproduction: 13 years of experience in 1,068 coasted cycles to prevent ovarian hyperstimulation

  • Hossam Abdalla, M.D.
    • ,
  • James D.M. Nicopoullos, M.D.

      Affiliations

    • Corresponding Author InformationReprint requests: James D. M. Nicopoullos, M.D., Lister Fertility Clinic, Lister Hospital, London SW1W 8RH, U.K. (FAX: +00442087468921).

Received 19 July 2009 ,Revised 27 September 2009 ,Accepted 29 September 2009.

References 

  1. Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update. 2002;8:559–577
  2. Delvigne A, Rozenberg S. Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Hum Reprod Update. 2003;9:77–96
  3. ASRM . Ovarian hyperstimulation syndrome. Fertil Steril. 2008;90:S188–S193
  4. RCOG . The management of ovarian hyperstimulation syndrome. Green-top guideline No. 5. London: Royal College of Obstetricians and Gynecologists; 2006;
  5. CEMACH . Saving mothers' lives: reviewing maternal deaths to make motherhood safer—2003–2005. London: Confidential Enquiry into Maternal and Child Health; 2007;
  6. Marci R, Senn A, Dessole S, Chanson A, Loumaye E, De Grandi P, et al. A low-dose stimulation protocol using highly purified follicle-stimulating hormone can lead to high pregnancy rates in in vitro fertilization patients with polycystic ovaries who are at risk of a high ovarian response to gonadotropins. Fertil Steril. 2001;75:1131–1135
  7. Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review. Reprod Biomed Online. 2007;14:640–649
  8. Kolibianakis EM, Schultze-Mosgau A, Schroer A, van Steirteghem A, Devroey P, Diedrich K, et al. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Hum Reprod. 2005;20:2887–2892
  9. Tang T, Glanville J, Orsi N, Barth JH, Balen AH. The use of metformin for women with PCOS undergoing IVF treatment. Hum Reprod. 2006;21:1416–1425
  10. Daya S, Gunby J. Luteal phase support in assisted reproduction cycles. Cochrane Database Syst Rev. 2004;CD004830
  11. Ferraretti AP, Gianaroli L, Magli C, Fortini D, Selman HA, Feliciani E. Elective cryopreservation of all pronucleate embryos in women at risk of ovarian hyperstimulation syndrome: efficiency and safety. Hum Reprod. 1999;14:1457–1460
  12. Egbase PE, Makhseed M, Al Sharhan M, Grudzinskas JG. Timed unilateral ovarian follicular aspiration prior to administration of human chorionic gonadotrophin for the prevention of severe ovarian hyperstimulation syndrome in in-vitro fertilization: a prospective randomized study. Hum Reprod. 1997;12:2603–2606
  13. Schroder AK, Schopper B, Al-Hasani S, Diedrich K, Ludwig M. Unilateral follicular aspiration and in-vitro maturation before contralateral oocyte retrieval: a method to prevent ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol. 2003;110:186–189
  14. Bellver J, Munoz EA, Ballesteros A, Soares SR, Bosch E, Simon C, et al. Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study. Hum Reprod. 2003;18:2283–2288
  15. Graf MA, Fischer R, Naether OG, Baukloh V, Tafel J, Nuckel M. Reduced incidence of ovarian hyperstimulation syndrome by prophylactic infusion of hydroxyaethyl starch solution in an in-vitro fertilization programme. Hum Reprod. 1997;12:2599–2602
  16. Alvarez C, Marti-Bonmati L, Novella-Maestre E, Sanz R, Gomez R, Fernandez-Sanchez M, et al. Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction. J Clin Endocrinol Metab. 2007;92:2931–2937
  17. Manno M, Tomei F, Marchesan E, Adamo V. Cabergoline: a safe, easy, cheap, and effective drug for prevention/treatment of ovarian hyperstimulation syndrome?. Eur J Obstet Gynecol Reprod Biol. 2005;122:127–128
  18. Sher G, Salem R, Feinman M, Dodge S, Zouves C, Knutzen V. Eliminating the risk of life-endangering complications following overstimulation with menotropin fertility agents: a report on women undergoing in vitro fertilization and embryo transfer. Obstet Gynecol. 1993;81:1009–1011
  19. Delvigne A, Rozenberg S. Preventive attitude of physicians to avoid OHSS in IVF patients. Hum Reprod. 2001;16:2491–2495
  20. Dhont M, Van der Straeten F, De Sutter P. Prevention of severe ovarian hyperstimulation by coasting. Fertil Steril. 1998;70:847–850
  21. Egbase PE, Sharhan MA, Grudzinskas JG. Early unilateral follicular aspiration compared with coasting for the prevention of severe ovarian hyperstimulation syndrome: a prospective randomized study. Hum Reprod. 1999;14:1421–1425
  22. D'Angelo A, Amso N. Coasting' (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev. 2002;CD002811
  23. Mansour R, Aboulghar M, Serour G, Amin Y, Abou-Setta AM. Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome. Hum Reprod. 2005;20:3167–3172
  24. Delvigne A, Rozenberg S. A qualitative systematic review of coasting, a procedure to avoid ovarian hyperstimulation syndrome in IVF patients. Hum Reprod Update. 2002;8:291–296
  25. Sher G, Zouves C, Feinman M, Maassarani G. “Prolonged coasting”: an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization. Hum Reprod. 1995;10:3107–3109
  26. García-Velasco JA, Zúñiga A, Pacheco A, Gómez R, Simón C, Remohí J, et al. Coasting acts through downregulation of VEGF gene expression and protein secretion. Hum Reprod. 2004;19:1530–1538
  27. Tortoriello DV, McGovern PG, Colon JM, Skurnick JH, Lipetz K, Santoro N. Coasting' does not adversely affect cycle outcome in a subset of highly responsive in vitro fertilization patients. Fertil Steri. 1998;69:454–460
  28. Ulug U, Bahceci M, Erden HF, Shalev E, Ben-Shlomo I. The significance of coasting duration during ovarian stimulation for conception in assisted fertilization cycles. Hum Reprod. 2002;17:310–313
  29. Isaza V, Garcia-Velasco JA, Aragones M, Remohi J, Simon C, Pellicer A. Oocyte and embryo quality after coasting: the experience from oocyte donation. Hum Reprod. 2002;17:1777–1782
  30. Waldenstrom U, Kahn J, Marsk L, Nilsson S. High pregnancy rates and successful prevention of severe ovarian hyperstimulation syndrome by “prolonged coasting” of very hyperstimulated patients: a multicentre study. Hum Reprod. 1999;14:294–297
  31. Nardo LG, Cheema P, Gelbaya TA, Horne G, Fitzgerald CT, Pease EH, et al. The optimal length of “coasting protocol” in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization. Hum Fertil. 2006;9:175–180
  32. Owj M, Tehrani Nejad E, Amirchaghmaghi E, Ezabadi Z, Baghestani AR. The effect of withholding gonadotropin (a coasting period) on the outcome of in vitro fertilization cycles. Eur J Obstet Gynecol Reprod Biol. 2007;133:81–85
  33. Moreno L, Diaz I, Pacheco A, Zuniga A, Requena A, Garcia-Velasco JA. Extended coasting duration exerts a negative impact on IVF cycle outcome due to premature luteinization. Reprod Biomed Online. 2004;9:500–504
  34. Garcia-Velasco JA, Isaza V, Quea G, Pellicer A. Coasting for the prevention of ovarian hyperstimulation syndrome: much ado about nothing?. Fertil Steril. 2006;85:547–554
  35. Enskog A, Henriksson M, Unander M, Nilsson L, Brannstrom M. Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril. 1999;71:808–814
  36. Moon HS, Joo BS, Moon SE, Lee SK, Kim KS, Koo JS. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome. Fertil Steril. 2008;90:2172–2178
  37. Erman Akar M, Oktay K. Falling FSH levels predict poor IVF pregnancy rates in patients whom the gonadotropins are withheld. Arch Gynecol Obstet. 2009;280:761–765
  38. Arslan M, Bocca S, Jones E, Mayer J, Stadtmauer L, Oehninger S. Effect of coasting on the implantation potential of embryos transferred after cryopreservation and thawing. Fertil Steril. 2005;84:867–874

 H.A. has nothing to disclose. J.N. has nothing to disclose.

PII: S0015-0282(09)03809-6

doi: 10.1016/j.fertnstert.2009.09.059

Fertility and Sterility
Volume 94, Issue 5 , Pages 1757-1763 , October 2010

Article Tools